Trial intelligence / Profile preview

Decitabine via HAI for Colorectal Cancer Liver Metastases

NCT02316028Phase 2Completed

Sponsor
UZ Brussel
Start
Mar 2014
Primary completion
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of decitabine in colorectal cancer (CRC), liver metastasis, sponsored by UZ Brussel. Started Mar 2014; status: completed.

02

Drugs

decitabine
03

Conditions

colorectal cancer (CRC)liver metastasis

Beyond the preview

Go deeper on NCT02316028.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02316028.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call